Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer Theranostics, 11:6873-6890, 2021
Prostate cancer (PCa) is the most commonly diagnosed cancer and the second leading cause of cancer death among American men 1. As the first-line chemotherapy for… Continue Reading